| [1] |
Leyking S, Fliser D. Insulin resistance in CKD [J]. Clin J Am Soc Nephrol, 2014, 9 (4): 638-640.
|
| [2] |
Shinohara K, Shoji T, Emoto M, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease [J]. J Am Soc Nephrol, 2002, 13 (7): 1894-1900.
|
| [3] |
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance [J]. Am J Physiol, 1979, 237(3): E214-E223.
|
| [4] |
Goodarzi MO, Cui J, Chen YD, et al. Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance [J]. Am J Physiol Endocrinol Metab, 2011, 301(2): E402-E408.
|
| [5] |
Jia T, Huang X, Qureshi AR, et al. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function [J]. Kidney Int, 2014, 86(2): 383-391.
|
| [6] |
Kanauchi M, Kimura K, Akai Y, et al. Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease [J]. Nephrol Dial Transplant, 2004, 19 (8): 2025-2029.
|
| [7] |
Kato Y, Hayashi M, Ohno Y, et al. Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis [J]. Clin Nephrol, 2000, 54 (5): 366-373.
|
| [8] |
de Boer IH, Zelnick L, Afkarian M, et al. Impaired glucose and insulin homeostasis in moderate-severe CKD[J]. J Am Soc Nephrol, 2016, 27(9): 2861-2871.
|
| [9] |
Jia T, Risérus U, Xu H, et al. Kidney function, β-cell function and glucose tolerance in older men [J]. J Clin Endocrinol Metab, 2015, 100 (2): 587-593.
|
| [10] |
DeFronzo RA, Alvestrand A, Smith D, et al. Insulin resistance in uremia [J]. J Clin Invest, 1981, 67 (2): 563-568.
|
| [11] |
Cecchin F, Ittoop O, Sinha MK, et al. Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats [J]. Am J Physiol, 1988, 254(4 Pt1): E394-E401.
|
| [12] |
Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review [J]. Am J Physiol Renal Physiol, 2016, 311(6): F1087-F1108.
|
| [13] |
Xu H, Huang X, Arnlov J, et al. Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4 [J]. Clin J Am Soc Nephrol, 2014, 9 (4): 690-697.
|
| [14] |
Schrauben SJ, Jepson C, Hsu JY, et al. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study [J]. BMC Nephrol, 2019, 20(1): 60.
|
| [15] |
He J, Shlipak M, Anderson A, et al. Risk factors for heart failure in patients with chronic kidney disease: the CRIC (chronic renal insufficiency cohort) study [J]. J Am Heart Assoc, 2017, 6(5): pii: e005336.
|
| [16] |
Li Y, Zhang L, Gu Y, et al. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis [J]. Perit Dial Int, 2013, 33(4): 411-418.
|
| [17] |
Fragoso A, Mendes F, Silva AP et al. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease [J]. J Diabetes Complications, 2015, 29(8): 1098-1104.
|
| [18] |
Nerpin E, Riserus U, Ingelsson E, et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a communitybased cohort [J]. Diabetes Care, 2008, 31 (8): 1550-1555.
|
| [19] |
Kobayashi H, Tokudome G, Hara Y, et al. Insulin resistance is a risk factor for the progression of chronic kidney disease [J]. Clin Nephrol, 2009, 71(6): 643-651.
|
| [20] |
Ma A, Liu F, Wang C, et al. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study [J]. Int Urol Nephrol, 2018, 50(12): 2239-2244.
|
| [21] |
Bowlby W, Zelnick LR, Henry C, et al. Physical activity and metabolic health in chronic kidney disease: a cross-sectional study [J]. BMC Nephrol, 2016, 17(1): 187.
|
| [22] |
Barcellos FC, Del Vecchio FB, Reges A, et al. Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial [J]. J Hum Hypertens, 2018, 32(6): 397-407.
|
| [23] |
Mustata S, Chan C, Lai V, et al. Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients [J]. J Am Soc Nephrol, 2004, 15(10): 2713-2718.
|
| [24] |
Kafeshani M, Janghorbani M, Salehi R, et al. Dietary approaches to stop hypertension influence on insulin receptor substrate-1gene expression: A randomized controlled clinical trial [J]. J Res Med Sci, 2015, 20(9): 832-837.
|
| [25] |
Entezari MH, Salehi R, Kazemi M, et al. Comparison of the effect of the dietary approaches to stop hypertension diet with usual dietary advice on expression of peroxisome proliferators-activated receptor gamma gene in women: a randomized controlled clinical trial [J]. ARYA Atheroscler, 2018, 14(1): 24-31.
|
| [26] |
Chen Z, Zuurmond MG, van der Schaft N, et al. Plant versus animal based diets and insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study [J]. Eur J Epidemiol, 2018, 33(9): 883-893.
|
| [27] |
Cui X, Wang B, Wu Y, et al. Vegetarians have a lower fasting insulin level and higher insulin sensitivity than matched omnivores: a cross-sectional study [J]. Nutr Metab Cardiovasc Dis, 2019, 29(5): 467-473.
|
| [28] |
Kelly JT, Palmer SC, Wai SN, et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies [J]. Clin J Am Soc Nephrol, 2017, 12(2): 272-279.
|
| [29] |
Kim H, Caulfield LE, Garcia-Larsen V, et al. Plant-based diets and incident CKD and Kidney function [J]. Clin J Am Soc Nephrol, 2019, 14(5): 682-691.
|
| [30] |
Garneata L, Stancu A, Dragomir D, et al. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression [J]. J Am Soc Nephrol, 2016, 27(7): 2164-2176.
|
| [31] |
Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease [J]. Clin J Am Soc Nephrol, 2011, 6(2): 257-264.
|
| [32] |
Goraya N, Simoni J, Jo CH, et al. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate [J]. Clin J Am Soc Nephrol, 2013, 8(3): 371-381.
|
| [33] |
Zanchi A, Tappy L, Lê KA, et al. Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study [J]. PLoS One, 2014, 9(10): e109134.
|
| [34] |
Friedman DJ, Bhatt N, Hayman NS, et al. Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients [J]. Clin Endocrinol (Oxf), 2012, 77(1): 56-61.
|
| [35] |
Fallah M, Askari G, Soleimani A, et al. Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients [J]. Int Urol Nephrol, 2018, 50(11): 2073-2079.
|
| [36] |
Satirapoj B, Supasyndh O, Phantana-Angkul P, et al. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes [J]. J Med Assoc Thai, 2011, 94(Suppl 4): S87-S93.
|
| [37] |
Chu PL, Chiu YL, Lin JW, et al. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance [J]. Blood Purif, 2008, 26(2): 213-220.
|
| [38] |
Kara M, Gurluler E, Caklr U. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients [J]. Ren Fail, 2015, 37(8): 1293-1296.
|